Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers

Abstract
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Funding Information
  • Hugs for Brady, The Val Skinner Foundation
  • National Institutes of Health (P30CA072720)
  • Genetics Diagnostics to Cancer Treatment Program
  • Rutgers Cancer Institute of New Jersey
  • Rutgers University Cell
  • DNA Repository Infinite Biologics